Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

South Korea flag South Korea · Delayed Price · Currency is KRW
82,800
+200 (0.24%)
Last updated: Oct 28, 2025, 2:22 PM KST
0.24%
Market Cap1.09T
Revenue (ttm)1.66T
Net Income (ttm)60.99B
Shares Out13.18M
EPS (ttm)4,623.22
PE Ratio17.87
Forward PE17.69
Dividend1,100.00 (1.33%)
Ex-Dividend DateDec 27, 2024
Volume16,693
Average Volume35,834
Open83,200
Previous Close82,600
Day's Range82,400 - 83,300
52-Week Range70,900 - 106,800
Beta0.61
RSI58.98
Earnings DateOct 27, 2025

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1941
Employees 2,253
Stock Exchange Korea Stock Exchange
Ticker Symbol 185750
Full Company Profile

Financial Performance

In 2024, KRX:185750's revenue was 1.59 trillion, a decrease of -4.97% compared to the previous year's 1.67 trillion. Earnings were 109.07 billion, a decrease of -48.68%.

Financial Statements

News

There is no news available yet.